18
Participants
Start Date
January 31, 2012
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Dexamethasone Phosphate Ophthalmic Solution (EGP-437)
Transcleral iontophoretic delivery of dexamethasone phosphate ophthalmic solution. Dexamethasone phosphate ophthalmic solution as a ready to use 40 mg/mL solution (preservative free and intended for single-use only).
Dexamethasone phosphate ophthalmic solution
Transcleral iontophoretic delivery of dexamethasone phosphate ophthalmic solution. Dexamethasone phosphate ophthalmic solution as a ready to use 40 mg/mL solution (preservative free and intended for single-use only)
Scheie Eye Institute/University of Pennsylvania, Philadelphia
Wilmer Eye Institute/Johns Hopkins University, Baltimore
University of California, San Francisco, San Francisco
University of Miami, Miami
Montefiore Medical Center, The Bronx
Oregon Health & Sciences University, Portland
John Kempen
OTHER